NCT01353625 2021-10-05Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.CelgenePhase 1 Completed118 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00004065 2013-06-24Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed